Condition
Lung Cancer|Mesothelioma
Estimated Enrollment: 28
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 2014-0497|NCI-2014-02568
Study First Received: November 11, 2014
Last Updated: February 15, 2017
Estimated Primary Completion Date: May 2021
Primary Outcome Measures:
Disease Control Rate (DCR)|Response Rate
Sponsors and Collaborators:
M.D. Anderson Cancer Center|Millennium Pharmaceuticals, Inc.
Website Link: https://ClinicalTrials.gov/show/NCT02293005
